glp 1 boost reviews consumer reports When millions of consumers change what they eat, the category mix changes with them. GLP-1 adoption is driving double-digit declines in high-calorie snacks and meaningful drops across sweets and beverages — while GLP-Activate | Hunger & Metabolism

The $99 genetic test add-on available after your first month of treatment bridges three decades of molecular research with 21st-century precision dosing

Tirzepatide carries a boxed warning for risk of thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2

Sulfur burps are one of the most talked-about side effects of GLP-1 medications like semaglutide and tirzepatide, even though GI effects like bloating, nausea, and constipation are more common

For the first time, the 2026 ADA Standards of Care guidelines suggests that physicians may consider GLP-1 medications in selected patients with type 1 diabetes and obesity

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease